OpenLegislation

Paragraph 33 Characteristics of the genetically modified organisms in their final formI1

Northern Ireland Not yet in force

Changes not yet applied. Later legislation changes this provision in ways not yet written into the text below:

In relation to human health, animal health and plant health –

(a)

the toxic or allergenic effects of the organisms and/or their metabolic products,

(b)

the comparison of the organisms to the donor, recipient or (where appropriate) parental organisms regarding pathogenicity,

(c)

the capacity of the organisms for colonisation, and

(d)

if the organisms are pathogenic to humans who are immunocompetent –

(i)

diseases caused and mechanism of pathogenicity including invasiveness and virulence,

(ii)

communicability,

(iii)

infective dose,

(iv)

host range and possibility of alteration,

(v)

possibility of survival outside of human host,

(vi)

presence of vectors or means of dissemination,

(vii)

biological stability,

(viii)

antibiotic resistance patterns,

(ix)

allergenicity, and

(x)

availability of appropriate therapies.

(e)

the other product hazards.

Annotations

Commencement

I1

Sch. 2 para. 33 in operation at 15.4.2003, see reg. 1